Matterworks
Matterworks makes complex biological data interpretable by converting mass spectrometry outputs into quantitative molecular readouts for life sciences applications. It does this through Pyxis, an AI-driven SaaS platform built on the company’s proprietary Large Spectral Model (LSM) and trained on extensive LC‑MS/MS (MS2) datasets to enable untargeted, absolute quantitation in minutes. The platform uses machine learning and spectral modeling to automate data processing and produce reproducible results without specialized manual workflows. Customers include life sciences researchers and biotech companies using the product for drug discovery, biomarker discovery, bioprocessing, and synthetic biology. Matterworks positions its technology as a scalable analytical layer that integrates with existing experimental mass‑spectrometry pipelines.
Matterworks
Matterworks makes complex biological data interpretable by converting mass spectrometry outputs into quantitative molecular readouts for life sciences applications. It does this through Pyxis, an AI-driven SaaS platform built on the company’s proprietary Large Spectral Model (LSM) and trained on extensive LC‑MS/MS (MS2) datasets to enable untargeted, absolute quantitation in minutes. The platform uses machine learning and spectral modeling to automate data processing and produce reproducible results without specialized manual workflows. Customers include life sciences researchers and biotech companies using the product for drug discovery, biomarker discovery, bioprocessing, and synthetic biology. Matterworks positions its technology as a scalable analytical layer that integrates with existing experimental mass‑spectrometry pipelines.